Combination of biologicals in indolent lymphoma: finally the end of chemotherapy era in indolent lymphoma?
Dreyling
Martin
M
Medizinische Klinik III der Universität Münich-Grosshadern, Germany. martin.dreyling@med.uni-muenchen.de
D001688:Biological Products / Q000627:therapeutic use*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D016896:Treatment Outcome
D001688:Biological Products; D007372:Interferons